Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Morphine × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 6 Neoplasms 6 Cancer Pain 6 Pain, Intractable 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Vesico-Ureteral Reflux 1 Ureteral Neoplasms 1 Thrombocythemia, Essential 1 Sigmoidal Tumour 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Postoperative 1 Nephrolithiasis 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Mucositis 1 Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Fluorouracil 131 Leucovorin 127 Oxaliplatin 93 Bevacizumab 85 Irinotecan 74 Capecitabine 63 Cetuximab 46 Folfox protocol 32 Panitumumab 18 regorafenib 16 trifluridine tipiracil drug combination 15 Drug Therapy 14 Chemotherapy, Adjuvant 13 IFL protocol 10 Floxuridine 10 Radiotherapy 9 Tegafur 7 Neoadjuvant Therapy 7 Levoleucovorin 7 Laparoscopy 7 Aspirin 7 pembrolizumab 6 Celecoxib 6 atezolizumab 5 XELOX 5 Trifluridine 5 Mitomycin 5 Colonoscopy 5 sintilimab 4 dehydroftorafur 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01318161 2021-02-16

EPICOL

Örebro University, Sweden

Phase 3 Terminated

Gastrointestinal

Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡